1 – 30 of 30
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Mammographic features at primary breast cancer diagnosis in relation to recurrence-free survival
(
- Contribution to journal › Article
- 2023
-
Mark
Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study
(
- Contribution to journal › Article
-
Mark
The role of primary care in the cancer care continuum : a qualitative study of cancer survivors’ experiences
(
- Contribution to journal › Article
-
Mark
Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI) : a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study
(
- Contribution to journal › Article
-
Mark
Investigating the prognostic value of mammographic breast density and mammographic tumor appearance in women with invasive breast cancer : The Malmö Diet and cancer study
(
- Contribution to journal › Article
-
Mark
Gene expression in metastatic breast cancer—patterns in primary tumors and metastatic tissue with prognostic potential
(
- Contribution to journal › Article
-
Mark
Performance of standardized cancer patient pathways in Sweden visualized using observational data and a state-transition model
(
- Contribution to journal › Article
- 2022
-
Mark
Peripheral Blood Mononuclear Cell Populations Correlate with Outcome in Patients with Metastatic Breast Cancer
(
- Contribution to journal › Article
- 2021
-
Mark
Pam50 intrinsic subtype profiles in primary and metastatic breast cancer show a significant shift toward more aggressive subtypes with prognostic implications
(
- Contribution to journal › Article
-
Mark
High levels of expression of cartilage oligomeric matrix protein in lymph node metastases in breast cancer are associated with reduced survival
(
- Contribution to journal › Article
- 2020
-
Mark
Human G-MDSCs are neutrophils at distinct maturation stages promoting tumor growth in breast cancer
(
- Contribution to journal › Article
-
Mark
Evolution of estrogen receptor status from primary tumors to metastasis and serially collected circulating tumor cells
(
- Contribution to journal › Article
-
Mark
Clinical relevance of systemic monocytic-MDSCs in patients with metastatic breast cancer
(
- Contribution to journal › Article
-
Mark
Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer
(
- Contribution to journal › Article
-
Mark
The distribution of circulating tumor cells is different in metastatic lobular compared to ductal carcinoma of the breast –long term prognostic significant
(
- Contribution to journal › Article
-
Mark
Mammographic tumour appearance is related to clinicopathological factors and surrogate molecular breast cancer subtype
(
- Contribution to journal › Article
- 2019
-
Mark
Impact of systemic therapy on circulating leukocyte populations in patients with metastatic breast cancer
(
- Contribution to journal › Article
- 2018
-
Mark
Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial
(
- Contribution to journal › Article
- 2017
-
Mark
Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy
(
- Contribution to journal › Article
- 2016
-
Mark
Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort
(
- Contribution to journal › Article
- 2015
-
Mark
A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
(
- Contribution to journal › Article
-
Mark
Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients.
(
- Contribution to journal › Article
-
Mark
Gene expression of breast cancer related genes in circulating tumour cells (CTCs) from patients with metastatic breast cancer
(
- Contribution to journal › Article
- 2014
-
Mark
EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation.
(
- Contribution to journal › Article
-
Mark
High frequency of myeloid-derived suppressor cells in sepsis patients, with the granulocytic subtype dominating in Gram-positive cases
(
- Contribution to journal › Published meeting abstract
- 2012
-
Mark
Translational Aspects of Erythropoietin Receptor and Hypoxia-Inducible Factors in Breast Cancer
(
- Thesis › Doctoral thesis (compilation)
- 2009
-
Mark
Erythropoietin Receptor Expression and Correlation to Tamoxifen Response and Prognosis in Breast Cancer.
(
- Contribution to journal › Article
- 2008
-
Mark
Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
(
- Contribution to journal › Article
- 2005
-
Mark
Epoetin alfa and darbepoetin alfa for the treatment of chemotherapy-related anemia in cancer patients in sweden: comparative analysis of drug utilization, costs, and hematologic response.
(
- Contribution to journal › Article
- 2004
-
Mark
Erythropoietin enhances response to treatment in patients with advanced breast cancer
(
- Contribution to journal › Debate/Note/Editorial